Workflow
中源协和(600645) - 2017 Q1 - 季度财报
VCANBIOVCANBIO(SH:600645)2017-04-28 16:00

Financial Performance - Operating revenue increased by 21.97% to CNY 208,881,365.93 year-on-year[6] - Net profit attributable to shareholders was CNY 27,680,157.25, a significant recovery from a loss of CNY 6,185,003.81 in the same period last year[6] - Total revenue for Q1 2017 was CNY 208,881,365.93, an increase of 22% compared to CNY 171,260,056.41 in the same period last year[29] - Net profit for Q1 2017 reached CNY 34,082,790.18, compared to a net loss of CNY 2,211,588.76 in Q1 2016[30] - Basic earnings per share for Q1 2017 were CNY 0.07, compared to a loss of CNY 0.02 per share in the same quarter last year[31] - The company reported a total comprehensive income of CNY 34,748,455.97 for Q1 2017, compared to a loss of CNY 2,217,592.19 in the previous year[31] Cash Flow - Cash flow from operating activities showed a net outflow of CNY 36,158,904.99, worsening from a net outflow of CNY 20,497,877.29 year-on-year[6] - Cash inflow from operating activities totaled 204,961,990.12 RMB, slightly up from 199,376,330.27 RMB year-over-year, reflecting a growth of about 0.9%[38] - The net cash flow from operating activities was -36,158,904.99 RMB, worsening from -20,497,877.29 RMB in the previous year, representing an increase in cash outflow of approximately 76.5%[38] - Cash flow from investing activities showed a net outflow of -40,991,283.02 RMB, an improvement from -78,794,349.62 RMB in the same quarter last year, indicating a reduction in investment losses by about 48%[38] - Cash flow from financing activities resulted in a net inflow of 3,628,145.49 RMB, compared to a net outflow of -6,983,988.33 RMB in the previous year, marking a significant turnaround[39] Assets and Liabilities - Total assets decreased by 2.35% to CNY 2,932,965,275.72 compared to the end of the previous year[6] - The company's total assets amounted to RMB 2,932,965,275.72, a decrease from RMB 3,003,634,603.21 at the beginning of the year[23] - The company's total liabilities as of March 31, 2017, were RMB 1,275,687,573.59, compared to RMB 1,251,829,042.59 at the beginning of the year[24] - The company's equity attributable to shareholders decreased to RMB 1,529,634,176.78 from RMB 1,587,829,968.63, a decline of approximately 3.7%[24] Investments and Financing - Investment activities generated a net cash inflow increase of 47.98%, primarily from the disposal of equity in Tianjin Angsai Cell Gene Engineering Co., Ltd.[13] - The company plans to transfer 38% equity of Tianjin Angsai Cell Gene Engineering Co., Ltd., which was approved in the board meeting[14] - The company signed a share transfer agreement, transferring 38% of Tianjin Angsai Cell Gene Engineering Co., Ltd. for RMB 45 million[15] - The company provided guarantees for loans totaling RMB 10 billion for related parties, including RMB 4 billion for Yongtai Hongkan Holdings Group Co., Ltd.[15] - The company provided a guarantee for a merger loan of RMB 77 million for its subsidiary, Xiehe Stem Cell Gene Engineering Co., Ltd.[16] - The company has provided guarantees for multiple trust loans totaling RMB 8 billion for Yongtai Hongkan Holdings Group Co., Ltd.[16] Expenses - Sales expenses increased by 63.44%, reflecting higher market investment by the company[12] - Total operating costs for Q1 2017 were CNY 192,937,503.07, up 32% from CNY 145,556,554.92 in the previous year[30] Other Financial Metrics - The weighted average return on equity improved to 1.76% from -0.40% in the previous year[6] - The company reported a gross profit margin of approximately 16% for Q1 2017, compared to 18% in the previous year[30] - The company's cash and cash equivalents decreased to RMB 204,097,046.94 from RMB 284,366,175.80 at the beginning of the year, representing a decline of approximately 28.2%[22] - The company's accounts receivable increased to RMB 206,224,031.54 from RMB 189,019,729.24, reflecting an increase of about 9.5%[22] - Long-term equity investments rose to CNY 1,738,143,399.90 from CNY 1,703,536,465.58, reflecting a 2% increase[27] - The total cash and cash equivalents at the end of the period were 204,097,046.94 RMB, down from 429,462,657.16 RMB year-over-year, a decrease of approximately 52.4%[39] - The company received 74,230,273.56 RMB from borrowings during the quarter, a decrease of about 73% compared to 278,172,684.23 RMB in the same period last year[39] - The total cash outflow from investing activities was 291,792,963.64 RMB, down from 839,434,403.75 RMB in the previous year, indicating a reduction of approximately 65.3%[38] - The company reported a cash inflow of 199,325,241.62 RMB from recovering investments, a significant decrease from 750,815,516.18 RMB in the previous year, reflecting a decline of about 73%[38] - The company’s cash flow from operating activities showed a net inflow of 44,549,090.66 RMB for the parent company, down from 74,508,107.25 RMB in the previous year, a decrease of approximately 40.2%[41]